Diagnostic yield of massively parallel sequencing in patients with chronic kidney disease of unknown etiology: rationale and design of a national prospective cohort study.
Amber de HaanMark EijgelsheimLiffert VogtBert van der ZwaagAlbertien M van EerdeNine V A M KnoersMartin H de BorstPublished in: BMJ open (2022)
Ethical approval for the study has been obtained from the institutional review board of the University Medical Center Groningen. Study findings should inform physicians and policymakers towards optimal implementation of MPS-based diagnostic testing in patients with unexplained CKD.